AFP and hepatocellular carcinoma: Therefore, the Mir@AFP panel (miRNA-21, miRNA-122, miRNA-192, and AFP) can be an innovative potent biomarker for screening of HCC in risk populations, thus improving early detection of HCC in HBV patients.